183 related articles for article (PubMed ID: 17138961)
1. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
Chadalavada RS; Korkola JE; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS
Stem Cells; 2007 Mar; 25(3):771-8. PubMed ID: 17138961
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
[TBL] [Abstract][Full Text] [Related]
3. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
4. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
5. Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3 alpha in models of early endodermal cell differentiation.
Roach S; Schmid W; Pera MF
Exp Cell Res; 1994 Nov; 215(1):189-98. PubMed ID: 7957668
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of urogenital ridge gene expression in the human embryonal carcinoma cell line NT2/D1.
Knower KC; Sim H; McClive PJ; Bowles J; Koopman P; Sinclair AH; Harley VR
Sex Dev; 2007; 1(2):114-26. PubMed ID: 18391522
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
[TBL] [Abstract][Full Text] [Related]
8. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Wakeman JA; Walsh J; Andrews PW
Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell.
Baselga J; Maerz WJ; Moy D; Miller WH; Castro L; Reuter VE; Yao TJ; Masui H; Dmitrovsky E
Oncogene; 1993 Dec; 8(12):3257-63. PubMed ID: 8247529
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
Pera MF; Bennett W; Cerretti DP
Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
[TBL] [Abstract][Full Text] [Related]
11. Human pluripotent embryonal carcinoma NTERA2 cl.D1 cells maintain their typical morphology in an angiomyogenic medium.
Simões PD; Ramos T
J Negat Results Biomed; 2007 Apr; 6():5. PubMed ID: 17442106
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of lineage differentiation in pluripotential human embryonal carcinoma cells.
Houldsworth J; Heath SC; Bosl GJ; Studer L; Chaganti RS
Cell Growth Differ; 2002 Jun; 13(6):257-64. PubMed ID: 12114215
[TBL] [Abstract][Full Text] [Related]
13. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
[TBL] [Abstract][Full Text] [Related]
14. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
Bahrami AR; Matin MM; Andrews PW
Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
[TBL] [Abstract][Full Text] [Related]
15. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.
Sumantran VN; Brederlau A; Funa K
Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid.
Kudoh T; Ishidate T; Nakamura T; Toyoshima K; Akiyama T
Oncogene; 1996 Oct; 13(7):1431-9. PubMed ID: 8875981
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells.
Chadalavada RS; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS
Funct Integr Genomics; 2005 Apr; 5(2):59-69. PubMed ID: 15690164
[TBL] [Abstract][Full Text] [Related]
18. Marked change in microRNA expression during neuronal differentiation of human teratocarcinoma NTera2D1 and mouse embryonal carcinoma P19 cells.
Hohjoh H; Fukushima T
Biochem Biophys Res Commun; 2007 Oct; 362(2):360-7. PubMed ID: 17716626
[TBL] [Abstract][Full Text] [Related]
19. [Impact of all-trans retinoic acid on gene expression profile of glioblastoma cell line SHG-44].
Zeng Y; Yang Z; Han YY; You C
Ai Zheng; 2008 May; 27(5):482-90. PubMed ID: 18479597
[TBL] [Abstract][Full Text] [Related]
20. Posttranscriptional control of human homeobox gene expression in induced NTERA-2 embryonal carcinoma cells.
Simeone A; Acampora D; D'Esposito M; Faiella A; Pannese M; Scotto L; Montanucci M; D'Alessandro G; Mavilio F; Boncinelli E
Mol Reprod Dev; 1989; 1(2):107-15. PubMed ID: 2576519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
